Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Filings indexed 604 across all filing types
Latest filing 2024-03-19 Annual Report
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2023
2024-03-19 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 19, 2024, by Scholar Rock Holding Corporation. It announces the issuance of a press release regarding financial and operating results for the year ended December 31, 2023. The document explicitly states that the press release is furnished as an exhibit and that the information is not "filed" for purposes of Section 18 of the Exchange Act, indicating this is an announcement rather than the full financial report itself. The document length is 3799 characters, which is relatively short and consistent with a report publication announcement rather than a full earnings release or annual report. The key phrase "issued a press release announcing its financial and operating results" and the fact that the press release is attached as an exhibit supports classification as an Earnings Release (ER). However, since the document itself is the Form 8-K announcing the press release and not the press release text itself, and the document is short, it fits best as a Regulatory Filing (RNS) announcing the earnings release rather than the earnings release itself. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-03-19 English
Director's Dealing 2024
Director's Dealing
2024-02-22 English
Director's Dealing 2024
Director's Dealing
2024-02-20 English
Director's Dealing 2024
Director's Dealing
2024-02-20 English
Director's Dealing 2024
Director's Dealing
2024-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.